The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc. (NASDAQ: VIVO) who purchased shares between March 25, 2016 and July 13, 2017. The action, which was filed in the United States District Court for the Southern District of Ohio, alleges that the Company violated federal securities laws.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Defendant’s lead tests provide inaccurate results; and (ii) as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.
Shareholders have until January 16, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
Please fill out the form to learn more